Hamed Alavi - Mar 13, 2024 Form 4 Insider Report for enVVeno Medical Corp (NVNO)

Role: Chief Technology Officer
Signature: /s/ Hamed Alavi
Stock symbol: NVNO
Transactions as of: Mar 13, 2024
Transactions value $: -$21,918
Form type: 4
Date filed: 3/15/2024, 08:00 PM
Previous filing: Dec 7, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVNO	Common Stock	Options Exercise	$29.9K	+8.33K		$3.59	8.33K	Mar 13, 2024	Direct
transaction	NVNO	Common Stock	Sale	-$51.8K	-8.33K	-100%	$6.22	0	Mar 13, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVNO	Stock Options	Options Exercise	$0	-8.33K	-8.33%	$0.00	91.7K	Mar 13, 2024	Common Stock	8.33K	$3.59	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Amended and Restated 2016 Omnibus Incentive Plan. The award is subject to time-based vesting and will vest in equal quarterly installments during the three calendar years through 2026. The portion of the stock options exercised in this transaction was fully vested and exercisable on the transaction date.

Content

The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Amended and Restated 2016 Omnibus Incentive Plan. The award is subject to time-based vesting and will vest in equal quarterly installments during the three calendar years through 2026. The portion of the stock options exercised in this transaction was fully vested and exercisable on the transaction date.